At close: December 13 at 4:00:01 PM EST
After hours: 7:43:44 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-74,748.00
-67,390.00
-49,109.00
-41,827.00
-29,809.00
Investing Cash Flow
129,170.00
-37,987.00
-22,272.00
-119,696.00
6,693.00
Financing Cash Flow
177,553.00
41,951.00
167,095.00
134,393.00
85,515.00
End Cash Position
269,868.00
79,926.00
143,235.00
47,699.00
74,854.00
Income Tax Paid Supplemental Data
--
28.00
3.00
238.00
178.00
Capital Expenditure
-86.00
-52.00
-275.00
-340.00
-584.00
Issuance of Capital Stock
175,999.00
41,611.00
167,253.00
136,362.00
69,377.00
Issuance of Debt
--
--
--
--
16,876.00
Repayment of Debt
--
--
--
-12,880.00
--
Free Cash Flow
-74,834.00
-67,442.00
-49,384.00
-42,167.00
-30,393.00
12/31/2020 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALT Altimmune, Inc.
9.03
+5.12%
GPCR Structure Therapeutics Inc.
31.25
-1.45%
CRVS Corvus Pharmaceuticals, Inc.
7.38
-8.66%
VKTX Viking Therapeutics, Inc.
47.03
-1.75%
KROS Keros Therapeutics, Inc.
18.83
+2.17%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.3100
-11.40%
ANAB AnaptysBio, Inc.
15.59
+3.79%
APVO Aptevo Therapeutics Inc.
4.0900
-27.35%
MDGL Madrigal Pharmaceuticals, Inc.
304.50
+0.67%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.6100
-5.78%